WO2001081368A3 - Polypeptides reduisant la tension sanguine et contenant vpp derives a partir de micro-organismes - Google Patents
Polypeptides reduisant la tension sanguine et contenant vpp derives a partir de micro-organismes Download PDFInfo
- Publication number
- WO2001081368A3 WO2001081368A3 PCT/US2001/012776 US0112776W WO0181368A3 WO 2001081368 A3 WO2001081368 A3 WO 2001081368A3 US 0112776 W US0112776 W US 0112776W WO 0181368 A3 WO0181368 A3 WO 0181368A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microorganisms
- blood
- derived
- pressure reducing
- polypeptides containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001255501A AU2001255501A1 (en) | 2000-04-21 | 2001-04-19 | Blood-pressure reducing polypeptides containing vpp derived from microorganisms |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19968000P | 2000-04-21 | 2000-04-21 | |
US60/199,680 | 2000-04-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001081368A2 WO2001081368A2 (fr) | 2001-11-01 |
WO2001081368A3 true WO2001081368A3 (fr) | 2002-05-16 |
Family
ID=22738560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/012776 WO2001081368A2 (fr) | 2000-04-21 | 2001-04-19 | Polypeptides reduisant la tension sanguine et contenant vpp derives a partir de micro-organismes |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001255501A1 (fr) |
WO (1) | WO2001081368A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI411441B (zh) * | 2003-03-18 | 2013-10-11 | Suntory Holdings Ltd | 血管收縮素轉化酶抑制性肽類 |
US20070207944A1 (en) * | 2004-07-12 | 2007-09-06 | Luppo Edens | Blood Pressure Lowering Oligopeptides |
CN101084004A (zh) * | 2004-12-22 | 2007-12-05 | 帝斯曼知识产权资产管理有限公司 | 单个酶促步骤中的血压降低寡肽 |
US20090042809A1 (en) * | 2005-04-28 | 2009-02-12 | Luppo Edens | Blood Pressure Lowering Protein Hydrolysates |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0583074A2 (fr) * | 1992-07-23 | 1994-02-16 | The Calpis Food Industry Co., Ltd. | Inhibiteur de l'enzyme de conversion de l'angiotensine et procédé pour le préparer |
WO1996017054A1 (fr) * | 1994-12-01 | 1996-06-06 | Oklahoma Medical Research Foundation | Technique et compositions permettant de reduire l'absorption de cholesterol |
WO1996037622A1 (fr) * | 1995-05-24 | 1996-11-28 | Astra Aktiebolag (Publ) | Molecules d'adn pour l'expression de la lipase stimulee par les sels biliaires (bssl) |
-
2001
- 2001-04-19 AU AU2001255501A patent/AU2001255501A1/en not_active Abandoned
- 2001-04-19 WO PCT/US2001/012776 patent/WO2001081368A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0583074A2 (fr) * | 1992-07-23 | 1994-02-16 | The Calpis Food Industry Co., Ltd. | Inhibiteur de l'enzyme de conversion de l'angiotensine et procédé pour le préparer |
WO1996017054A1 (fr) * | 1994-12-01 | 1996-06-06 | Oklahoma Medical Research Foundation | Technique et compositions permettant de reduire l'absorption de cholesterol |
WO1996037622A1 (fr) * | 1995-05-24 | 1996-11-28 | Astra Aktiebolag (Publ) | Molecules d'adn pour l'expression de la lipase stimulee par les sels biliaires (bssl) |
Also Published As
Publication number | Publication date |
---|---|
WO2001081368A2 (fr) | 2001-11-01 |
AU2001255501A1 (en) | 2001-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7038600A (en) | Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof | |
WO2001058412A3 (fr) | Extraits de residus de la production de vin | |
EP1293503A4 (fr) | Derives de triazole | |
ZA200203867B (en) | alpha-Amino acids compounds, a process for their preparation and pharmaceutical compositions containing them. | |
AP2003002916A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
CA2567582A1 (fr) | Complement dietetique anti-hypertensif derive d'hydrolysats de proteines de saumon ou d'oncorhynchus | |
HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
HUP0200623A3 (en) | 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors and pharmaceutical compositions containing them | |
EP1550448A4 (fr) | Inhibiteur de la liberation d'histamine | |
AU2002243005A1 (en) | Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods | |
CA2450093A1 (fr) | Polymorphe stable de flibanserine, procede de preparation associe et utilisation dudit polymorphe dans la preparation de medicaments | |
WO2003087050A3 (fr) | Sel de perindopril et les compositions pharmaceutiques qui le contiennent | |
CA2431998A1 (fr) | Concentres d'arome | |
AU2002238855A1 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
WO2002056708A3 (fr) | Preparation destinee a ameliorer l'assimilation des aliments | |
HUP0400155A3 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
WO2003099192A8 (fr) | Alcanols bi-aromatiques | |
WO2001080873A3 (fr) | Peptide de modulation du recepteur de la thrombopoietine | |
MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
EE05491B1 (et) | Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena | |
WO2004031202A3 (fr) | Palatinose condense sous forme hydrogenee | |
AU2002241408A1 (en) | Modular system of dietary supplement compositions comprising vitamins | |
WO2003049687A3 (fr) | Compositions medicinales et methodes therapeutiques | |
WO2001081368A3 (fr) | Polypeptides reduisant la tension sanguine et contenant vpp derives a partir de micro-organismes | |
AU2003302188A1 (en) | Method of obtaining a soothing active ingredient, active ingredient and compositions obtained |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |